CoChat

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action

Open access
Jaquet, Vincent, Marcoux, Julien, Forest, Eric, Leidal, Kevin G, McCormick, Sally, Westermaier, Yvonne, Perozzo, Remo, Plastre, Olivier, Fioraso‐Cartier, Laetitia, Diebold, Becky, Scapozza, Leonardo, Nauseef, William M, Fieschi, Franck, Krause, Karl‐Heinz, Bedard, Karen · 2011 · British Journal of Pharmacology
Cited by 119

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND Celastrol is one of several bioactive compounds extracted from the medicinal plant Tripterygium wilfordii. Celastrol is used to treat inflammatory conditions, and shows benefits in models of neurodegenerative disease, cancer and arthritis, although its mechanism of action is incompletely understood. EXPERIMENTAL APPROACH Celastrol was tested on human NADPH oxidases (NOXs) using a panel of experiments: production of reactive oxygen species and oxygen consumption by NOX enzymes, xanthine oxidase activity, cell toxicity, phagocyte oxidase subunit translocation, and binding to cytosolic subunits of NOX enzymes. The effect of celastrol was compared with diphenyleneiodonium, an established inhibitor of flavoproteins. KEY RESULTS Low concentrations of celastrol completely inhibited NOX1, NOX2, NOX4 and NOX5 within minutes with concentration–response curves exhibiting higher Hill coefficients and lower IC 50 values for NOX1 and NOX2 compared with NOX4 and NOX5, suggesting differences in their mode of action. In a cell‐free system, celastrol had an IC 50 of 1.24 and 8.4 µM for NOX2 and NOX5, respectively. Cytotoxicity, oxidant scavenging, and inhibition of p47 phox translocation could not account for NOX inhibition. Celastrol bound to a recombinant p47 phox and disrupted the binding of the proline rich region of p22 phox to the tandem SH3 domain of p47 phox and NOXO1, the cytosolic subunits of NOX2 and NOX1, respectively. CONCLUSIONS AND IMPLICATIONS These results demonstrate that celastrol is a potent inhibitor of NOX enzymes in general with increased potency against NOX1 and NOX2. Furthermore, inhibition of NOX1 and NOX2 was mediated via a novel mode of action, namely inhibition of a functional association between cytosolic subunits and the membrane flavocytochrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01439.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 119

Metadata

Authors
Jaquet, V., Marcoux, J., Forest, E., Leidal, K. G., McCormick, S., Westermaier, Y., Perozzo, R., Plastre, O., Fioraso‐Cartier, L., Diebold, B., Scapozza, L., Nauseef, W. M., Fieschi, F., Krause, K., & Bedard, K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-08-28
Volume
164
Issue
2b
Pages
507-520
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1560738700
Cited by
119
References
7
FWCI
18.44
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01439.x
The paper
Jaquet, V., Marcoux, J., Forest, E., Leidal, K. G., McCormick, S., Westermaier, Y., Perozzo, R., Plastre, O., Fioraso‐Cartier, L., Diebold, B., Scapozza, L., Nauseef, W. M., Fieschi, F., Krause, K., & Bedard, K. (2011). NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01439.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.